Effects of Repeated Electroconvulsive Therapy Sessions on Anesthetic Requirements
REPEAT-ECT
1 other identifier
observational
60
1 country
1
Brief Summary
Electroconvulsive therapy (ECT) is an effective treatment for severe depression and other psychiatric disorders. ECT is usually given in several sessions on different days. During each session, patients receive short-acting anesthesia to ensure comfort and safety. This study aims to evaluate whether the amount of anesthetic medication required changes during repeated ECT sessions in the same patient. In addition, the study will examine the relationship between anesthetic dose, seizure duration, seizure quality (measured by postictal suppression index), and recovery time. This is a prospective observational study. All anesthesia and ECT procedures will be performed according to routine clinical practice. No additional intervention will be applied for research purposes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2026
CompletedFirst Posted
Study publicly available on registry
February 18, 2026
CompletedStudy Start
First participant enrolled
March 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 13, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 13, 2026
CompletedJune 16, 2026
June 1, 2026
3 months
February 11, 2026
June 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Anesthetic Dose Requirement Across Repeated ECT Sessions
Dose (mg) of the anesthetic agent administered for each ECT session (e.g., propofol or etomidate), recorded from anesthesia records and analyzed as within-subject change across sequential sessions.
Across the first 4 ECT sessions per participant (from Session 1 to Session 4), during the study period (up to 3 months).
Study Arms (1)
Adults Undergoing Repeated ECT
Adult patients aged 18-65 years with an indication for electroconvulsive therapy (ECT) who are scheduled to undergo multiple ECT sessions under routine clinical practice. All anesthesia and ECT procedures will be performed according to standard institutional protocols. No additional intervention will be applied for research purposes. Repeated within-subject measurements will be collected across ECT sessions.
Interventions
Electroconvulsive therapy administered as part of routine clinical care. The study does not assign or modify the intervention. Anesthetic management and ECT parameters are determined by treating physicians according to standard institutional protocols.
Eligibility Criteria
Adult patients aged 18-65 years with an established indication for electroconvulsive therapy (ECT) who are scheduled to undergo multiple ECT sessions at a tertiary care hospital. Participants will be consecutively enrolled during the study period according to eligibility criteria. All procedures will be performed as part of routine clinical care.
You may qualify if:
- Age 18 to 65 years.
- Scheduled to undergo electroconvulsive therapy (ECT) under elective conditions as part of routine clinical care.
- ECT indication (e.g., major depressive disorder, bipolar depression, schizoaffective disorder, catatonia).
- ASA Physical Status I-III.
- Planned to receive multiple ECT sessions.
- Able to provide written informed consent (participant and/or legally authorized representative).
You may not qualify if:
- Use of antiepileptic drugs or benzodiazepines that may affect seizure threshold.
- ECT received within the past 6 months.
- Severe cardiovascular, pulmonary, or neurologic comorbidity (investigator judgment).
- Pregnancy or breastfeeding.
- ASA Physical Status IV or higher.
- Acute substance or alcohol use disorder/intoxication.
- Conditions preventing EEG monitoring (e.g., scalp trauma, significant skin lesions, cranial implants).
- Inability to obtain reliable BIS monitoring during anesthesia induction due to technical limitations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Izmir City Hospital
Izmir, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiology and Reanimation Specialist, MD
Study Record Dates
First Submitted
February 11, 2026
First Posted
February 18, 2026
Study Start
March 15, 2026
Primary Completion
June 13, 2026
Study Completion
June 13, 2026
Last Updated
June 16, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share